Emerging Trends In The CDMO Landscape With Bend Bioscience
Dr. Michael Grass, Head of Product Innovation at Bend Bioscience, brings over 11 years of experience in the pharmaceutical drug product industry. With a strong background in oral delivery of low bioavailability molecules, particle engineering, solid form development, materials science, and analytical methods, he has contributed to more than 50 scientific publications and patents. Michael holds a B.A. in chemistry from Pomona College and a Ph.D. in physical chemistry from the University of California at Berkeley.
In this interview, Michael discusses how Bend Bioscience is adapting to emerging trends in the CDMO landscape, driving innovation, and enhancing pharmaceutical product development.
To learn more about how Bend Bioscience can make your molecules and medicines remarkable, contact them at Innovation@BendBioscience.com.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.